Karlheinz Hilber

8PUBLICATIONS
19CO-AUTHORS
Electrical energy generation (incl. renewables, excl. photovoltaics)Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 12, 2025
The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels.

Jakob Sauer, Jessica Marksteiner, Martin Hohenegger

|Aug 11, 2025
Inhibition of tenascin C rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes.

Jessica Marksteiner, Jakob Sauer, Martin Hohenegger

|Dec 15, 2023
Empagliflozin treatment rescues abnormally reduced Na+ currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice.

Jakob Sauer, Jessica Marksteiner, Elena Lilliu

|Apr 09, 2023
Ivabradine acutely improves cardiac Ca handling and function in a rat model of Duchenne muscular dystrophy.

Petra Lujza Szabo, Jessica Marksteiner, Janine Ebner

|Aug 02, 2022
Microdystrophin Therapy Rescues Impaired Na Currents in Cardiac Purkinje Fibers From Dystrophin-Deficient Mdx Mice.

Janine Ebner, Xiufang Pan, Yongping Yue

|May 09, 2020
Reduced Na+ current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy.

Janine Ebner, Pavel Uhrin, Petra L Szabo

Pageof 2